Male

New Poll Shows Overwhelming Demand for Skilled Trades Classes in L.A. County High Schools

Retrieved on: 
Thursday, March 21, 2024

Eighty-seven percent of voters agree that it “was a mistake” to remove classes in subjects including carpentry, welding, transportation mechanics, and other skilled trades from most Los Angeles high schools and identify this removal as a convincing reason to expand skilled trades education in public high schools.

Key Points: 
  • Eighty-seven percent of voters agree that it “was a mistake” to remove classes in subjects including carpentry, welding, transportation mechanics, and other skilled trades from most Los Angeles high schools and identify this removal as a convincing reason to expand skilled trades education in public high schools.
  • Today, fewer than 1 in 5 public high schools in L.A. County’s 80 school districts offer any type of skilled trades education.
  • Merely 20 schools across the county offer classes in construction and only one offers an electrical course, despite nationwide labor shortages in these high-paying fields.
  • The mission of Harbor Freight Tools for Schools is to increase support and understanding of, and investment in, skilled trades education in U.S. public high schools.

Demeetra and Indiana University Biopesticide Platform Combining Gene Editing and Synthetic Biology Selected as a MDPI Journal Editor’s Choice Article

Retrieved on: 
Wednesday, March 20, 2024

A pioneering study, authored by scientists from Demeetra and Indiana University, has been selected for the MDPI Journals Editor's Choice Articles , highlighting the impact of advanced gene editing in synthetic biology to produce biopesticides.

Key Points: 
  • A pioneering study, authored by scientists from Demeetra and Indiana University, has been selected for the MDPI Journals Editor's Choice Articles , highlighting the impact of advanced gene editing in synthetic biology to produce biopesticides.
  • View the full release here: https://www.businesswire.com/news/home/20240320823585/en/
    Demeetra and Indiana University research on gene edited yeast biopesticide was featured on the front cover of Fermentation.
  • According to MDPI “Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world.
  • “We wanted to engineer the ideal yeast platform for stable RNAi expression,” said Dr. Corey Brizzee, Director of Gene Editing at Demeetra.

Eight Sleep Names Taylor Fritz as Athlete Ambassador and Investor to Power the Next Generation of Tennis Legends

Retrieved on: 
Wednesday, March 20, 2024

Eight Sleep , the world’s first sleep fitness company, today announces that Taylor Fritz, the highest-ranked American male Tennis player, joins the company as an Athlete Ambassador and Investor.

Key Points: 
  • Eight Sleep , the world’s first sleep fitness company, today announces that Taylor Fritz, the highest-ranked American male Tennis player, joins the company as an Athlete Ambassador and Investor.
  • As Fritz and other young talent challenge the long-term reign of tennis legends, every detail matters - including getting quality sleep - when it comes to finding a performance edge and winning matches.
  • Fritz began using Eight Sleep’s Pod in early 2023 as a way to optimize sleep and recovery and enhance his on-court performance.
  • Fritz will also be creating content with Eight Sleep to spread awareness of the importance of sleep fitness and healthy sleep habits for young athletes.

YourChoice Therapeutics Scientific Advisory Board member updates phase 1a study for male birth control candidate at ACS Spring 24

Retrieved on: 
Tuesday, March 19, 2024

YourChoice Therapeutics, a San Francisco biotech startup developing the first hormone-free male birth control pill, announced today that Gunda Georg, YCT-529’s co-inventor, provided an update on its phase 1a clinical study for the first hormone-free male birth control pill, YCT-529, at the American Chemical Society (ACS) 2024 Spring Meeting.

Key Points: 
  • YourChoice Therapeutics, a San Francisco biotech startup developing the first hormone-free male birth control pill, announced today that Gunda Georg, YCT-529’s co-inventor, provided an update on its phase 1a clinical study for the first hormone-free male birth control pill, YCT-529, at the American Chemical Society (ACS) 2024 Spring Meeting.
  • The phase 1a study investigates the safety, tolerability, pharmacokinetics, and pharmacodynamics of single, ascending oral doses of YCT-529 in 16 participants.
  • I’m pleased to be a part of that future.”
    YCT-529 is a hormone-free birth control candidate currently under investigation.
  • “Men and women want more birth control options, and they want them to be hormone-free,” said Akash Bakshi, co-founder and CEO of YourChoice Therapeutics.

‘Ask Viamo Anything’ Combines AI with Basic Mobile Calls to Bring Next Billion Online

Retrieved on: 
Friday, March 15, 2024

By bringing the latest iteration of AI to some of the world’s poorest and most remote communities, ‘Ask Viamo Anything’ heralds the fastest democratisation of technology to date.

Key Points: 
  • By bringing the latest iteration of AI to some of the world’s poorest and most remote communities, ‘Ask Viamo Anything’ heralds the fastest democratisation of technology to date.
  • “Generative AI shouldn’t just help lawyers in LA do their job 10% better,” says David McAfee, the CEO and Cofounder of platform provider Viamo.
  • By using basic voice calls as the interface, the Viamo platform is accessible to more people than can currently log onto Facebook, Instagram or TikTok.
  • “Combining AI and mobile is the necessary solution to bring the next billion people online,” says McAfee.

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, March 13, 2024

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and fourth quarter and full year 2023 financial results, including meaningful data to support advancement of its neurology pipeline.

Key Points: 
  • Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and fourth quarter and full year 2023 financial results, including meaningful data to support advancement of its neurology pipeline.
  • “In 2023, Sangamo announced the prioritization of its pipeline programs that support our focus as a neurology-focused genomic medicine company,” said Sandy Macrae, Chief Executive Officer of Sangamo.
  • STAC-BBB was well tolerated in NHPs, with no notable treatment related pathological findings in brain, spinal cord or peripheral tissues.
  • Revenues for the fourth quarter ended December 31, 2023 were $2.0 million, compared to $27.2 million for the same period in 2022.

Fidelity Investments® Research: Retirement Transforming as 2-In-3 Americans Live More Intentionally Post-Pandemic

Retrieved on: 
Tuesday, March 12, 2024

Across generations, two-thirds look forward to pursuing work for pleasure while in retirement and hope for a phased retirement – working full-time at first, then part-time, before stopping altogether.

Key Points: 
  • Across generations, two-thirds look forward to pursuing work for pleasure while in retirement and hope for a phased retirement – working full-time at first, then part-time, before stopping altogether.
  • “Americans are approaching their ‘golden years’ with more intention and opportunity than ever before,” said Rita Assaf, vice president of Retirement Products at Fidelity Investments.
  • Fidelity also created the Fidelity Retirement Score℠ , which provides a rough estimate of how much people may need in retirement and suggests ways to help improve their score.
  • Plus, for those with Fidelity workplace retirement accounts, there is access to one-on-one appointments, phone consultations and workshops through their employers.

Survey Reveals New Era of Financial Independence as Millennials Seek to Redefine Retirement

Retrieved on: 
Monday, March 11, 2024

A new survey reveals how millennials are reshaping the retirement landscape, defining it by financial independence rather than an age-based benchmark.

Key Points: 
  • A new survey reveals how millennials are reshaping the retirement landscape, defining it by financial independence rather than an age-based benchmark.
  • The study, which marks a new understanding of retirement planning’s shifting paradigms, surveyed millennials nationwide, shedding light on the evolving attitudes and behaviors surrounding their retirement readiness, retirement confidence, and consumer debt.
  • The survey was commissioned by IRALOGIX , a retirement industry fintech provider, and took place in February 2024.
  • "The survey underscores a fundamental shift from what we previously understood: millennials don't perceive retirement solely as a departure from the workforce.

Egg Innovations is Set to Introduce In-Ovo Technology to Help Eliminate Chick Culling Practices within the Egg Industry

Retrieved on: 
Thursday, April 4, 2024

WARSAW, Ind., April 4, 2024 /PRNewswire/ -- As the continuous leader in animal welfare within the egg industry, Egg Innovations has committed to furthering its mission by being the first U.S. based company committed to implementing in-ovo sexing technology to populate their family farms. Introducing in-ovo sexing, which is only available in Europe today, Egg Innovations is determined to be the catalyst to help eliminate chick culling within the American egg industry.

Key Points: 
  • Leadership from Egg Innovations is pioneering the industry as the first company committed to utilize the in-ovo sexing technology, eliminating male chick culling.
  • Introducing in-ovo sexing, which is only available in Europe today, Egg Innovations is determined to be the catalyst to help eliminate chick culling within the American egg industry.
  • John Brunnquell, Ph.D., Founder and CEO of Egg Innovations, states, "Humane care is the ethos in which Egg Innovations was founded.
  • By utilizing this in-ovo sexing technology, Egg Innovations will be able to implement practices for more humane egg production that avoids the practice of male chick culling.

Reneé Touponce, Executive Chef at Mystic's Oyster Club and The Port of Call, is Named a Finalist for Outstanding Chef in the 2024 James Beard Awards

Retrieved on: 
Thursday, April 4, 2024

MYSTIC, Conn., April 4, 2024 /PRNewswire/ -- Reneé Touponce, executive chef at Oyster Club and The Port of Call in Mystic, has been named a finalist in the 2024 James Beard Awards in the category of Outstanding Chef.

Key Points: 
  • MYSTIC, Conn., April 4, 2024 /PRNewswire/ -- Reneé Touponce, executive chef at Oyster Club and The Port of Call in Mystic, has been named a finalist in the 2024 James Beard Awards in the category of Outstanding Chef.
  • Touponce's nomination not only celebrates her exceptional culinary talent but also acknowledges her unwavering commitment to diversity, inclusivity, and innovation in the kitchen.
  • The James Beard Awards are the highest honor in the culinary world, recognizing excellence and innovation in the field.
  • The winners of the 2024 James Beard Awards will be announced at a gala event in Chicago on June 10th.